Deals channel feed – Endpoints News

Deals channel feed

Merck KGaA pays Abbisko $85M for full commercial rights to benign tumor drug

Last month

Why Miga Health's co-founders decided to quit building

Last month

Aurion CEO is out as Alcon takes majority stake in cell therapy startup

Last month

WuXi Biologics’ licensing deals help offset Biosecure threat in the US

2 months ago

Merck strikes deal for heart drug, worth up to $2B, with China’s Hengrui

2 months ago

Novo Nordisk pays $200M upfront for China-based biotech’s triple-G obesity shot

2 months ago

The buildup to Chimerix's $935M exit to Jazz, with more than half a dozen parties intrigued

2 months ago

AstraZeneca broadens presence in China, promising $8B+ to Harbour and Syneron

2 months ago

Paratek boosts commercial portfolio in move to buy Optinose and its nasal spray

2 months ago

Sanofi to pay $600M upfront for Dren Bio’s bispecific B cell depleter

2 months ago

Roche inks $1B+ biobucks deal with UK biotech for new antibody cancer targets

2 months ago

Servier pays $70M upfront for Black Diamond’s RAS- and RAF-targeted cancer drug

2 months ago

AstraZeneca taps Alteogen in deal worth more than $1.3B to make subcutaneous cancer drugs

2 months ago

Otsuka's Taiho buys Swiss startup Araris with three ADCs nearing the clinic

2 months ago

AstraZeneca to buy cell therapy startup for $425M upfront

2 months ago

MeiraGTx teams with cryptic AI startup, co-founded by Eric Schmidt, to advance Parkinson's gene therapy

2 months ago

Acelyrin, Pliant turn to ‘poison pill’ as Kevin Tang’s Concentra pursues both companies

2 months ago

Updated: Endo and Mallinckrodt to merge in $6.7B deal

2 months ago

Mallinckrodt and Endo exploring a $7B merger — report

2 months ago

Ono licenses rare blood disease drug from Ionis for $280M upfront

2 months ago

Updated: Zealand partners with Roche on its amylin analog in a deal worth up to $5.3B

2 months ago

Endo sells international business for $84M

2 months ago

Bristol Myers buys out cell therapy partner 2seventy bio

2 months ago

Sun Pharma to acquire Checkpoint Therapeutics and its anti-PD-L1 antibody

2 months ago

First page Previous page 1 234 5 6 Next page Last page